Measuring neutralizing antibody levels after COVID-19 vaccination
Neutralizing Antibody Level After COVID-19 Vaccination in Hospital Works.
This study looks at how long neutralizing antibodies last after COVID-19 vaccination in healthcare workers and checks if different factors affect these levels.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 51 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | Kyungpook National University Hospital Academic / other |
| Locations | 1 site (Daegu) |
| Trial ID | NCT05083026 on ClinicalTrials.gov |
What this trial studies
This observational study measures the levels of neutralizing antibodies at various intervals (2, 4, 6, 9, and 12 months) following COVID-19 vaccination in healthcare workers. It aims to identify factors that may influence antibody titers, such as age, sex, body weight, and medication use. Additionally, the study will compare the performance of four different diagnostic ELISA kits in measuring these antibody levels at the two-month mark. The goal is to understand the duration of antibody response and the reliability of different testing methods.
Who should consider this trial
Good fit: Ideal candidates for this study are healthcare workers aged 20-60 who have completed their COVID-19 vaccination.
Not a fit: Patients with serious underlying diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the longevity of vaccine-induced immunity and inform booster vaccination strategies.
How similar studies have performed: Other studies have shown success in measuring antibody responses post-vaccination, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * healthcare works after completion of COVID-19 vaccination * 20-60 years * sign the agreement of study Exclusion Criteria: * serious underlying diseases
Where this trial is running
Daegu
- Kyungpook National University Hospital — Daegu, Korea, Republic of (Recruiting)
Study contacts
- Principal investigator: Su Youn Nam, MD, PhD — Kyungpook National University Hospital
- Study coordinator: Su Youn Nam, MD, PhD
- Email: nam20131114@gmail.com
- Phone: 82-53-200-2610
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.